TY - JOUR AU - Pandey, K. N. PY - 2008 DA - 2008// TI - Emerging roles of natriuretic peptides and their receptors in pathophysiology of hypertension and cardiovascular hypertension JO - J Am Soc Hypertens VL - 2 UR - https://doi.org/10.1016/j.jash.2008.02.001 DO - 10.1016/j.jash.2008.02.001 ID - Pandey2008 ER - TY - JOUR AU - Gu, J. AU - Noe, A. AU - Chandra, P. AU - Al-Fayoumi, S. AU - Ligueros-Saylan, M. AU - Sarangapani, R. AU - Maahs, S. AU - Ksander, G. AU - Rigel, D. F. AU - Jeng, A. Y. AU - Lin, T. H. AU - Zheng, W. AU - Dole, W. P. PY - 2010 DA - 2010// TI - Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNI) JO - J Clin Pharmacol VL - 50 UR - https://doi.org/10.1177/0091270009343932 DO - 10.1177/0091270009343932 ID - Gu2010 ER - TY - JOUR AU - Ruilope, L. M. AU - Dukat, A. AU - Bohm, M. AU - Lacourciere, Y. AU - Gong, J. AU - Lefkowitz, M. P. PY - 2010 DA - 2010// TI - Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind placebo-controlled, active comparator study JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(09)61966-8 DO - 10.1016/S0140-6736(09)61966-8 ID - Ruilope2010 ER - TY - JOUR AU - Kobalava, Z. AU - Pavlikova, E. AU - Averkov, O. AU - Moiseev, V. AU - Albrecht, D. AU - Feng, A. AU - Priyamvada, C. AU - Jordaan, P. J. PY - 2010 DA - 2010// TI - First experience with concomitant AT1 and neprilysin inhibition with LCZ696 in patients with chronic heart failure JO - Circulation VL - 122 ID - Kobalava2010 ER - TY - STD TI - identifier NCT01035255, [http://Clinicaltrials.gov] UR - http://Clinicaltrials.gov ID - ref5 ER - TY - STD TI - identifier NCT00887588, [http://Clinicaltrials.gov] UR - http://Clinicaltrials.gov ID - ref6 ER -